BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 22633099)

  • 1. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
    Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
    Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis.
    Salamone F; Galvano F; Marino Gammazza A; Paternostro C; Tibullo D; Bucchieri F; Mangiameli A; Parola M; Bugianesi E; Li Volti G
    Dig Liver Dis; 2012 Apr; 44(4):334-42. PubMed ID: 22197629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
    Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats.
    Luo ZL; Tang LJ; Wang T; Dai RW; Ren JD; Cheng L; Xiang K; Tian FZ
    J Gastroenterol Hepatol; 2014 Jan; 29(1):215-22. PubMed ID: 24117897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
    dela Peña A; Leclercq IA; Williams J; Farrell GC
    J Hepatol; 2007 Feb; 46(2):304-13. PubMed ID: 17157947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.
    Nan YM; Wu WJ; Fu N; Liang BL; Wang RQ; Li LX; Zhao SX; Zhao JM; Yu J
    Scand J Gastroenterol; 2009; 44(9):1121-31. PubMed ID: 19606393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
    Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
    Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
    Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
    Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
    Leclercq IA; Farrell GC; Sempoux C; dela Peña A; Horsmans Y
    J Hepatol; 2004 Dec; 41(6):926-34. PubMed ID: 15582125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
    Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
    Jun DW; Cho WK; Jun JH; Kwon HJ; Jang KS; Kim HJ; Jeon HJ; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Lee MH
    Liver Int; 2011 Oct; 31(9):1315-24. PubMed ID: 22093454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.